Induction of differentiation by 1α-hydroxyvitamin D5 in T47D human breast cancer cells and its interaction with vitamin D receptors
- 30 April 2000
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 36 (6), 780-786
- https://doi.org/10.1016/s0959-8049(00)00016-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Prevention of Preneoplastic Mammary Lesion Development by a Novel Vitamin D Analogue, 1 -Hydroxyvitamin D5JNCI Journal of the National Cancer Institute, 1997
- EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1993
- Effects of synthetic vitamin d analogues on breast cancer cell proliferation in vivo and in vitroBiochemical Pharmacology, 1992
- RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elementsCell, 1991
- Topical calcipotriol treatment in advanced breast cancerThe Lancet, 1991
- In vitro study of effects of 1,25 dihydroxyvitamin D3 on the morphology of human breast cancer cell line BT.20Differentiation, 1989
- POSSIBLE ROLE FOR VITAMIN D IN CONTROLLING BREAST CANCER CELL PROLIFERATIONThe Lancet, 1989
- Vitamin D Receptors: Nature and FunctionAnnual Review of Nutrition, 1986
- Effect of 1 α-hydroxyvitamin D3 on metastasis of rat ascites hepatoma K-231British Journal of Cancer, 1984
- Synthesis of vitamin D5: Its biological activity relative to vitamins D3 and D2Archives of Biochemistry and Biophysics, 1979